Trial intelligence / Profile preview

Drug use surveillance of Takecab (vonoprazan) tablets for peptic ulcer and reflux esophagitis

jRCT1080223122Completed

Sponsor
Takeda
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of vonoprazan in gastric ulcer, duodenal ulcer and erosive esophagitis (EE), sponsored by Takeda. Started Mar 2016; status: completed.

02

Drugs

vonoprazan
03

Conditions

gastric ulcerduodenal ulcererosive esophagitis (EE)

Beyond the preview

Go deeper on jRCT1080223122.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080223122.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call